Table 1.
Baseline Characteristicsa
| Characteristic | Total Patients = 967 |
|---|---|
| Age in years, median (IQR) | 10.2 (7.8–12.6) |
| Female | 487 (50.4) |
| Mode of HIV infection | |
| Perinatal | 922 (95.4) |
| Other | 10 (1.0) |
| Unknown | 35 (3.6) |
| Orphan status | |
| Both parents alive | 237 (24.5) |
| Single parent alive | 276 (28.5) |
| Neither parent alive | 358 (37.0) |
| Unknown | 96 (9.9) |
| Primary care giver | |
| Parents | 372 (38.5) |
| Grandparent | 183 (18.9) |
| Relative/nonrelative/foster care | 234 (24.2) |
| Unknown | 178 (18.4) |
| CD4 cell count in cells/mm3, median (IQR) | 837 (602–1092) |
| WHO category | |
| 1/2 | 437 (45.2) |
| 3 | 333 (34.4) |
| 4 | 197 (20.4) |
| Height-for-age z-score, median (IQR), N = 941 | −1.7 (−2.5 to −1.0) |
| Weight-for-age z-score, median (IQR), N = 942 | −1.7 (−2.5 to −0.9) |
| Anemic, n (%tested), N = 619 | 47 (7.6) |
| HBsAg positive, n (%tested), N = 761 | 36 (4.7) |
| Hepatitis C antibody positive, n (%tested), N = 182 | 5 (2.7) |
| Antiretroviral therapy | |
| NRTI-NNRTI | 760 (78.6) |
| NRTI-PI | 189 (19.5) |
| Other | 18 (1.9) |
Abbreviations: HBsAg, hepatitis B surface antigen; HIV, human immunodeficiency virus; IQR, interquartile range; N, number of patients with data available; NNRTI, nonnucleoside reverse-transcriptase inhibitor; NRTI, nucleoside reverse-transcriptase inhibitor; PI, protease inhibitor; WHO, World Health Organization.
aValues are n (%total) unless otherwise specified.